report
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
Key markets include Indonesia, the Philippines, and Australia.
2 days ago
Oral proteins and peptides market to hit $24b by 2030
Its expansion is attributed to the prevalence of chronic diseases like diabetes.
2 days ago
Physicians divided over patient choice in biologics vs biosimilars
China’s physicians expressed the highest support amongst surveyed countries.
2 days ago
Global cardiac monitoring market to be valued at $13.24b by 2030
By end user, the hospital segment accounts for the largest market share.
2 days ago
Smart hospitals market to surpass $161.6b by 2033
Thanks to healthcare automation, AI, and IoT-based medical devices.
3 days ago
7MM COPD market to hit $30.2b in 2033
Triple therapy inhalers are expected to account for 11.3% of the total market.
4 days ago
What drives the shoulder arthroplasty field?
Improved fixation techniques are helping prevent failures and reduce repeat surgeries.
4 days ago
What to expect with APAC’s elder care products market?
The global market is expected to reach $45b by the end of 2032.
4 days ago
Australia’s PET imaging agents market to see 2% CAGR growth until 2033
The sector’s expansion is driven by a surge in prostate cancer cases.
4 days ago
Singapore’s oncology landscape to advance with histotripsy technology
The approach is an ultrasound-based technique that offers a pain-free alternative.
4 days ago
Global injectible drug delivery devices market to hit $317.2b by 2029
Biologic drug development is driving the demand for advanced injectable delivery systems.
6 days ago
China’s mechanical heart valves market to reach $50m in 2033
The country accounts for about 50% of the market share in the Asia Pacific.
6 days ago
7MM regulatory T-cell market to grow over 57% CAGR by 2034
Currently, no Treg-based therapies are approved.
India's healthcare expenditure to rise to 5% of GDP by 2030
The growth is driven by structural improvements within the sector.
What can we expect from Turkiye’s health sector?
Persistent economic instability remains a key constraint.
Cytogenetics market to be valued at $5.5b by 2031
Its growth is attributed to the rising prevalence of genetic disorders and cancer.
Healthcare payers lag in digital maturity: report
AI solutions could cut costs and increase revenue for payers.